1,531 results on '"Miyajima, Akira"'
Search Results
302. MP71-13 EFFICACY OF CHEMOTHERAPY ADMINISTRATION IN ELDERLY PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY.
303. PD15-06 IMPACT OF TUMOR LOCATION ON BIOCHEMICAL RECURRENCE OF PT3 PROSTATE CANCER
304. Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen
305. Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma
306. Simple and practical nomograms for predicting the stone-free rate after shock wave lithotripsy in patients with a solitary upper ureteral stone
307. Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy
308. Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy
309. Should We Try Antiandrogen Withdrawal in Castration-Resistant Prostate Cancer Patients? Insights From a Retrospective Study
310. Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery?
311. Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.
312. Clinical experience of laparoscopic adrenalectomy : the National Defense Medical College experience
313. Should We Try Antiandrogen Withdrawal in Castration-Resistant Prostate Cancer Patients? Insights From a Retrospective Study
314. 脂肪酸受容体と内臓脂肪に着目した腎癌進展メカニズムの解明
315. Carcinosarcoma of the renal pelvis and ureter : a case report
316. Influence of physician years on urological journal publication productivity among Japanese urologists
317. Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation
318. Novel algorithm for management of acute epididymitis
319. Laparoendoscopic single-site surgeries: A multicenter experience of 469 cases in Japan
320. Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?
321. The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking
322. Urinary pH Levels are Strongly Associated with Bladder Recurrence After Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients with a Smoking History
323. Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers
324. Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms
325. High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy
326. The learning curve of laparoendoscopic single-site adrenalectomy: an analysis of over 100 cases
327. The prognostic significance of OCT4 expression in patients with prostate cancer
328. MP90-09 A NEW STRATEGY FOR THE TREATMENT OF PROSTATE CANCER BY TARGETING VASOHIBIN-2
329. MP27-05 ARE CALCULATED FORMULAS FOR ESTIMATING RENAL FUNCTION ADEQUATE FOR ADMINISTERED CISPLATIN-BASED CHEMOTHERAPY IN SOLITARY RENAL PATIENTS AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA?
330. PD13-12 EXTERNAL VALIDATION OF PROGNOSTIC IMPACT OF PATIENT AGE AND GENDER IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: PROPOSED NEW PERSPECTIVE OF GENDER-ADJUSTED AGE IN UPPER TRACT UROTHELIAL CARCINOMA
331. MP27-18 IMPACT OF MAXIMUM TUMOR DIAMETER ADJUSTED BY PRIMARY TUMOR LOCATION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA MANAGED BY RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL STUDY
332. MP39-20 ARE THERE ANY APPROPRIATE CRITERIA FOR RECOMMENDING PROSTATE BIOPSY IN PATIENTS OVER 75 YEARS OLD?
333. MP84-20 BIOINFORMATIC ANALYSIS UTILIZING THE ANDROGENIC SUPPRESSIVE EFFECT IDENTIFIED PROMISING CANDIDATE DRUGS FOR REPROGRAMMING DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER
334. MP27-02 PROGNOSTIC ROLE OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSION IN SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA.
335. MP40-07 LONG-TERM FOLLOW-UP DATA AFTER RADICAL PROSTATECTOMY: DETERMINING WHEN TO STOP PSA MONITORING
336. S&T-06 HIGH ABSOLUTE MONOCYTE COUNT PREDICTS POOR CLINICAL OUTCOME IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH DOCETAXEL CHEMOTHERAPY
337. MP13-01 PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO IS A USEFUL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH A PREVIOUS HISTORY OF SMOKING.
338. MP03-03 METASTATIC RENAL CELL CARCINOMA TO THE BLADDER: SYSTEMATIC REVIEW OF 113 REPORTED CASES
339. MP13-17 CHARACTERIZING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: IMPLICATIONS FOR THE DEFINITION OF INTERMEDIATE RISK AND TREATMENT STRATEGY
340. MP90-03 REACTIVE OXYGEN SPECIES INDUCTION BY CABAZITAXEL VIA INHIBITION OF THE SESTRIN FAMILY IN CASTRATION-RESISTANT PROSTATE CANCER
341. MP54-04 SIMPLE AND PRACTICAL NOMOGRAMS FOR PREDICTING STONE-FREE RATE AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN PATIENTS WITH SOLITARY STONE IN UPPER URINARY TRACT
342. A prospective longitudinal survey of erectile function status in symptomatic benign prostatic hyperplasia patients treated with dutasteride
343. Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urology
344. Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin
345. Prognostic role of programmed cell death protein 1 expression in surgically treated patients with upper tract urothelial carcinoma.
346. Impact of precise quantitative assessment of visceral obesity on outcomes of patients with metastatic renal cell carcinoma treated with systemic therapy.
347. Variant isoforms of CD44 expression as predictive markers for mortality in surgically treated patients with locally advanced upper tract urothelial carcinoma.
348. 腎細胞癌における上皮間葉転換に着目した新規標的分子の探索
349. Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients
350. Erectile function status is highly associated with prostate‐specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.